Total synthesis of 11-deoxyanthracyclines: 4-demethoxy-11-deoxy-daunomycin, 11-deoxydaunomycin, and their analoguesTAMURA, Y; AKAI, S; KISHIMOTO, H et al.Chemical and pharmaceutical bulletin. 1988, Vol 36, Num 10, pp 3897-3914, issn 0009-2363Article

14-Fluoroanthracyclines. Novel syntheses and antitumor activityMATSUMOTO, T; OHSAKI, M; YAMADA, K et al.Chemical and pharmaceutical bulletin. 1988, Vol 36, Num 10, pp 3793-3804, issn 0009-2363Article

Re-searching anthracycline therapyOAKMAN, Catherine; MORETTI, Erica; DI LEO, Angelo et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 171-175, issn 0167-6806, 5 p.Article

Adriamycin and other anthracyclinesEHRKE, M. J; MIHICH, E.Clinics in immunology and allergy. 1984, Vol 4, Num 2, pp 259-277, issn 0260-4639Article

Thin-layer chromatographic separation of new semisynthetic derivatives of daunomycinoneJIZBA, J. V; PRIKRYLOVA, V; LIPAVSKA, H et al.Journal of chromatography. 1983, Vol 257, Num 1, pp 185-187, issn 0021-9673Article

7-deoxydaunomycinone, a catalyst for achieving a two-electron reduction with a one-electron reducing agentKLEYER, D. L; KOCH, T. H.Journal of the American Chemical Society. 1983, Vol 105, Num 18, pp 5911-5912, issn 0002-7863Article

Prévention de la cardiotoxicité des anthracyclines : approche fondamentale des mécanismes mis en jeu ; relations avec les données cliniques = Preventing the cardiotoxic effects of anthracyclins. from basic concepts to clinical dataDELEMASURE, S; VERGELY, C; ZELLER, M et al.Annales de cardiologie et d'angéiologie (Paris). 2006, Vol 55, Num 2, pp 104-112, issn 0003-3928, 9 p.Article

Redox-cycling of anthracyclines by thioredoxin system : Increased superoxide generation and DNA damageRAVI, Dashnamoorthy; DAS, Kumuda C.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 5, pp 449-458, issn 0344-5704, 10 p.Article

New anthracycline derivatives : what for ?MROSS, K.European journal of cancer (1990). 1991, Vol 27, Num 12, pp 1542-1544, issn 0959-8049Article

ADRIAMYCIN-ACTIVATED MACROPHAGES AS TUMOR GROWTH INHIBITORSHASKILL JS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3852-3856; BIBL. 16 REF.Article

Pathogenesis of cardiotoxicity induced by anthracyclinesELLIOTT, Perry.Seminars in oncology. 2006, Vol 33, Num 3, issn 0093-7754, S2-S7, SUP8Conference Paper

Microbial conversion of anthracycline antibiotics. IV: Study on the glycosidation of ε-pyrromycinone by Streptomyces galilaeus OBB-111-848HOSHINO, T; FUJIWARA, A.Journal of antibiotics (Tokyo. 1968). 1984, Vol 37, Num 11, pp 1473-1474, issn 0021-8820Article

Comptes-rendus/Anthracyclines: place actuelle et développements futurs, symposium, Marrakech, Maroc, 29-31 mai 1986 = Reports anthracyclines: present results in futur trends, symposium, Marrakech, Morocco, May 29-31, 1986Transactions of the Zoological Society of London. 1987, Vol 35, Num 1, pp 5-128, issn 0084-5620Conference Proceedings

Risque cardiaque de l'adriamycine. Repérage précoce des sujets à haut risque par l'étude fonctionnelle cardiaque isotopique = Cardiac risk of adriamycin. Early cardiac isotopic detection of high risk subjectsPECKING, A; DELORME, G; BERLIE, J et al.La Presse médicale (1983). 1983, Vol 12, Num 39, pp 2445-2448, issn 0755-4982Article

EFFECTS OF ACLACINOMYCIN-A ON MURINE LEUKEMIANARA N; MIYAMOTO T; HIRASHIMA K et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 60; NO 1; PP. 188-193; BIBL. 16 REF.Article

L'adriamycine = AdriamycineCOLBERT, N; IZRAEL, V.La Revue du praticien (Paris). 1984, Vol 34, Num 16, pp 753-757, issn 0035-2640Article

Effects of daunomycin and daunomycin-protein conjugates on the ultrastructure of Trypanosoma rhodesienseWILLIAMSON, J; MCLAREN, D. J; BROWN, J. R et al.Cell biology international reports. 1983, Vol 7, Num 12, pp 997-1005, issn 0309-1651Article

Does anthracycline administration by infusion in children affect late cardiotoxicity?LEVITT, G. A; DORUP, I; SORENSEN, K et al.British journal of haematology. 2004, Vol 124, Num 4, pp 463-468, issn 0007-1048, 6 p.Article

Anthracyclines during pregnancy: embryo-fetal outcome in 160 patientsGERMANN, N; GOFFINET, F; GOLDWASSER, F et al.Annals of oncology. 2004, Vol 15, Num 1, pp 146-150, issn 0923-7534, 5 p.Article

Monitoring of Anthracycline-Induced CardiotoxicityJANNAZZO, Abigail; HOFFMAN, Janet; LUTZ, Mark et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 1, pp 99-104, issn 1060-0280, 6 p.Article

QT Dispersion correlates with systolic rather than diastolic parameters in patients receiving anthracycline treatmentNAKAMAE, Hirohisa; TSUMURA, Kei; OHTA, Kensuke et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 5, pp 379-387, issn 0918-2918, 9 p.Article

Anthracycline mechanisms in analogue selectionACTON, E. M.Drugs under experimental and clinical research. 1985, Vol 11, Num 1, pp 1-8, issn 0378-6501Article

Hematological aspects of a novel 9-aminoanthracycline, amrubicinOBARA, Naoshi; IMAGAWA, Shigehiko; NAKANO, Yoko et al.Cancer science. 2003, Vol 94, Num 12, pp 1104-1106, issn 1347-9032, 3 p.Article

Pharmacocinétique des nouvelles anthracyclines = Pharmacokinetics of some new anthracycline antibioticsROBERT, J.Bulletin du cancer. 1988, Vol 75, Num 2, pp 167-174, issn 0007-4551Article

Aclarubicin: experimetal and clinical experienceRÖTHIG, H.-J; KRAEMER, H. P; SEDLACEK, H. H et al.Drugs under experimental and clinical research. 1985, Vol 11, Num 2, pp 123-125, issn 0378-6501Article